glp-1 prescription process Researchers find medications safe to continue before surgery in patients with diabetes and obesity GLP-1 Medications for Weight Loss:

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Huanbutta K., Burapapadh K., Kraisit P., et al

References Wegovy (semaglutide) Prescribing Information Novo Nordisk FDA Drug Label Zepbound (tirzepatide) Prescribing Information Eli Lilly FDA Drug Label Saxenda (liraglutide) Prescribing Information Novo Nordisk FDA Drug Label Limitations This is not dosing advice

What matters is consistency

Sufficient water intake maintains the gut microbiota and immune homeostasis and promotes pathogen elimination

As many as two-thirds of people using a GLP-1 to lose weight stop taking the drug within a year, citing unpleasant side effects (diarrhea, constipation, nausea and vomiting) and the relatively high cost of the medication